DeviceTalks Podcast Network

In this episode of DeviceTalks Weekly, CathWorks CEO Ramin Mousavi explains how the company built a surprisingly fast path to acquisition.

Founded in 2018, the startup was forced to go back to the drawing board. By incorporating LLMs and other advances, CathWorks developed a better way to diagnose heart disease—leading to a strategic investment from Medtronic in 2022 and a full acquisition announced this week.

Mousavi also shares his personal path into MedTech, including the unlikely story of an Iranian-American leading an Israel-based startup. In a conversation with Host Tom Salemi, he reflects on how employees kept the company’s mission front and center through constant change.

In this week’s FOMO, Managing Editor Kayleen Brown draws on her own experience with Type 2 diabetes to explore how Dexcom is using data and AI. She speaks with Girish Naganathan, EVP and Chief Technology Officer at Dexcom.

Plus, MassDevice Editor Chris Newmarker delivers Newmarker’s Newsmakers, featuring Medtronic, Siemens Healthineers, Stryker, Boston Scientific, and Applied Medical.

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:02:38) - State of Minnesota / Newmarker’s Newsmakers
(00:08:00) - Medtronic Structural Heart President Nina Goodheart to retire
(00:09:11) - Siemens Healthineers unveils $12M R&D facility in Ireland
(00:12:10) - Stryker officials have high hopes for 2026 with Mako RPS
(00:13:54) - Boston Scientific posts Q4 beats as sales rise 16%, stock dips as EP sales come up short
(00:16:19) - Medtronic reportedly must pay Applied Medical $382M over antitrust suit
(00:21:52) - FOMO Interview – Girish Naganathan, EVP, Chief Technology Officer, Dexcom
(00:32:28) - Keynote Interview – Ramin Mousavi, President, CEO, CathWorks

In this week’s episode of DeviceTalks Weekly, neurosurgeon Adam Arthur, MD, explains why he’s trading surgical scrubs for the chance to help lead Medtronic’s Neurovascular business as its new chief medical officer. Dr. Arthur joins Host Tom Salemi to discuss how neurosurgery is reaching more patients today—and what it must do to expand its impact in the years ahead.

Before the keynote interview, Managing Editor Kayleen Brown speaks with Brittany Mai of Confluent Medical Technologies about the future of neuro and minimally invasive surgery. Thank you to Confluent for sponsoring this week’s episode. Learn more at ConfluentMedical.com.

At the top of the show, MassDevice Editor Chris Newmarker talks with Wayne Paterson, CEO of Anteris Technologies, about the company’s new agreement with Medtronic and what it means for the future of TAVR.

Thank you for listening to DeviceTalks Weekly!

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:03:38) - Chris Newmarker interviews Wayne Paterson, CEO of Anteris Technologies
(00:06:10) - This is not your Father’s TAVR
(00:08:00) - Terms of the Medtronic investment
(00:25:30) - Kayleen Brown sits down with Brittany Mai of Confluent Medical
(00:29:50) - How is minimally invasive technology changing?
(00:31:28) - Keynote conversation – Adam Arthur, MD, new chief medical officer for Medtronic Neurovascular
(00:35:30) - What makes a good neurosurgeon?
(00:39:01) - Choosing impact over intimacy
(00:44:50) - What do patients fear more than death?
(00:49:45) - More focus needed on Women’s neurological health including chronic refractory migraine

In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Jupiter Endovascular CEO Carl St. Bernard about the “soft” design of the company's TFX technology, designed to simplify the complicated procedure of clearing cardiovascular blockages, including pulmonary artery embolisms. Jupiter is recording fundraising and clinical trials wins. St. Bernard shares what’s next.

In this week’s FOMO, Kayleen Brown interviews Javier Olea, Life Science Segment Director at Averna about test and measurement in medical device manufacturing. Visit www.averna.com to learn more.

We open the episode with this week’s Newsmakers compiled by MassDevice Editor Chris Newmarker – Merge, OpenAI, Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Anteris Technologies.

To register for our upcoming Cardiac Innovation series go here: https://event.on24.com/wcc/r/5203526/B4EE367D76F7ECCAC132665B50E61A7C/5516160?partnerref=Podcast

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:06:00) - #5 - OpenAI invests in Sam Altman’s Merge Labs BCI startup
(00:08:30) - #4 - Abbott picks up CE mark for TactiFlex dual-energy ablation catheter
(00:11:27) - #3 - Johnson & Johnson MedTech sales up 7.5% in Q4
(00:13:24) - #2 - Boston Scientific has a potentially serious Axios stent recall
(00:15:00) - #1 - Medtronic to invest up to $90M in Anteris Technologies
(00:21:20) - FOMO - Advancing Test & Measurement Strategies in MedTech Manufacturing with Javier Olea of Averna
(00:32:50) - Keynote Interview: Carl St. Bernard, CEO, Jupiter Endovascular

In this episode of DeviceTalks Weekly, Rob Binney, CEO of ShiraTronics, explains how the neurostimulation device is working to provide some relief for people suffering from chronic migraines. Binney’s career started in pharma, but he’s built a MedTech career at significant companies including AccessClosure, Intersect ENT before taking his first CEO role at Alydia Health.

In our FOMO interview, Steven Mickelsen, MD, chief technology officer and founder of Field Medical, details the different challenges in taking on ventricular cardiac arrhythmias vs. atrial fibrillation where he built his monumental success.

Dr. Mickelsen will also share Field Medical’s story at our DeviceTalks Cardiac Innovations Series taking place Feb 3-5. Register at DeviceTalks.com to watch live or on demand.

MassDevice’s Chris Newmarker brings his Newmarker’s Newsmakers – Johnson & Johnson MedTech, Edwards Lifesciences, Distalmotion, Intuitive Surgical, Medtronic, and Boston Scientific.

***

Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.

Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

Chapters

(00:05:12) - Distalmotion secures funding from J&J to support Dexter rollout in ASCs
(00:06:43) - Edwards gives up on $1.2B JenaValve acquisition
(00:09:00) - Intuitive says daVinci systems ‘exceeded expectations,’ it wants more
(00:11:12) - Medtronic has ‘significant firepower’ to boost M&A
(00:13:08) - All the big news from Boston Scientific
(00:20:10) - FOMO – Steven Mickelsen, MD, Founder, Field Medical
(00:27:40) - Keynote Interview, Rob Binney, CEO, ShiraTronics

Innovation doesn’t happen by accident. It happens when leaders intentionally design the systems that allow curiosity, experimentation, and good ideas to survive.

In this episode of the Women in MedTech podcast, host Kayleen Brown sits down with Dr. Rebecca Gottlieb, VP of Advanced Sensor Technologies at Biolinq, to explore what it really takes to build innovation engines inside regulated MedTech environments. From early clinical work with artificial heart patients, to more than two decades of sensor innovation at Medtronic, to leading advanced biosensing platforms at Biolinq, Rebecca explains why curiosity isn’t just a mindset — it’s a leadership strategy.

Kayleen also welcomes Chris Dawson, Head of Biosensing at TTP PLC, to unpack what curiosity looks like in practice: how multidisciplinary teams explore what’s possible, retire risk early, and build systems that support innovation without compromising reliability or regulatory rigor. Thank you to TTP for your support, to learn more visit: https://www.ttp.com.

Before you go, make sure to download your complimentary e-books from TTP today! 

Rethinking Regulatory Compliance -  How to turn regulatory demands in MedTech into development strengths

Optimising Bluetooth Connectivity in Implantable Medical Devices

Automated Biosensor Testing for the Development of Continuous Health Monitors

***

Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players:
https://women-in-medtech.castos.com/subscribe

Follow us on YouTube:
https://www.youtube.com/@DeviceTalks

Want access to the complete DeviceTalks Podcast Network (DTPN)?
Follow us at https://devicetalks.castos.com/subscribe

Chapters

(00:00:00) - Why innovation systems matter in MedTech
(00:00:01) - Introducing in-studio guest, Chris Dawson, TTP
(00:00:02) - What innovation looks like inside multidisciplinary teams
(00:00:03) - Start of keynote interview with Rebecca Gottlieb, Biolinq
(00:00:04) - From startup to Medtronic: scaling innovation across environments
(00:00:05) - Internal venture programs: designing systems for ideas to surface
(00:00:06) - Leadership as barrier removal, not control
(00:00:07) - Why Rebecca chose Biolinq: platforms, microneedles, and possibility
(00:00:08) - Rethinking glucose monitoring for Type 2 diabetes
(00:00:09) - FDA De Novo clearance and sustaining teams through long timelines
(00:00:10) - The future of biosensing: DNA-based receptors and new analytes
(00:00:11) - Leadership reflections and closing: curiosity as an innovation engine